The neuroprotective effect of dexmedetomidine and its mechanism
Dexmedetomidine (DEX) is a highly selective α2 receptor agonist that is routinely used in the clinic for sedation and anesthesia. Recently, an increasing number of studies have shown that DEX has a protective effect against brain injury caused by traumatic brain injury (TBI), subarachnoid hemorrhage...
Main Authors: | Yijun Hu, Hong Zhou, Huanxin Zhang, Yunlong Sui, Zhen Zhang, Yuntao Zou, Kunquan Li, Yunyi Zhao, Jiangbo Xie, Lunzhong Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-09-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2022.965661/full |
Similar Items
-
Anesthesia, the developing brain, and dexmedetomidine for neuroprotection
by: Alexandra Tsivitis, et al.
Published: (2023-06-01) -
Neuroprotective Effects of Dexmedetomidine on the Ketamine-Induced Disruption of the Proliferation and Differentiation of Developing Neural Stem Cells in the Subventricular Zone
by: Huanhuan Sha, et al.
Published: (2021-07-01) -
Taming Postoperative Delirium with Dexmedetomidine: A Review of the Therapeutic Agent’s Neuroprotective Effects following Surgery
by: Vincent Bargnes, et al.
Published: (2023-10-01) -
The Role of miRNAs in Dexmedetomidine’s Neuroprotective Effects against Brain Disorders
by: Codrin-Constantin Burlacu, et al.
Published: (2022-05-01) -
MicroRNA-323-5p Involved in Dexmedetomidine Preconditioning Impart Neuroprotection
by: Hyunyoung Seong, et al.
Published: (2023-08-01)